Financial instrument risk disclosures

IFRS 7 disclosures are the primary window analysts, rating agencies, and regulators have into a bank's risk profile beyond the numbers on the face of the statements; because a bank's business is fundamentally about taking and managing credit, liquidity, and market risk, generic or boilerplate disclosure here directly undermines the market's ability to assess capital adequacy, funding resilience, and earnings sensitivity, arguably more consequential for a bank than for almost any other industry.

Does the concentration analysis by sector, geography, and single-name counterparty reflect the bank's actual portfolio composition for this period, rather than rolled-forward prior-year figures? Is the liquidity maturity ladder built on a contractual, undiscounted basis distinct from any internal behavioral or discounted view used by treasury? Are market risk sensitivities (interest rate, FX, equity) calibrated to how the bank's own ALM/treasury function actually monitors these exposures rather than an arbitrary shock size?

1. Map the bank's actual risk management structure (credit committee reports, ALCO packs, market risk limits) to determine what quantitative and qualitative disclosures will be genuinely representative rather than generic.
2. Prepare concentration analysis by sector, geography, and single-name/counterparty exposure for credit risk.
3. Build a contractual, undiscounted maturity ladder for liquidity risk covering both assets and liabilities, distinguishing it from any internally used behavioral or discounted view.
4. Quantify market risk sensitivity (parallel and non-parallel yield curve shifts, FX shocks, equity price shocks) consistent with how the bank's treasury/ALM function actually monitors these risks.
5. Decide whether risk disclosures will sit within the audited notes or be cross-referenced to a separate risk management report, and if cross-referenced, clearly flag which parts are audited versus unaudited.
6. Update all quantitative disclosures each reporting period; do not roll forward prior-year figures unchanged.

Quantify credit risk exposure by internal rating grade and IFRS 9 stage, showing gross exposure, loss allowance, and net exposure; quantify liquidity risk through a contractual maturity ladder on an undiscounted cash flow basis, including off-balance-sheet commitments; quantify market risk through sensitivity analysis reflecting reasonably possible shifts (e.g., a defined basis-point parallel shift for interest rate risk, a defined percentage move for FX and equity), calibrated to how management actually assesses these exposures, not an arbitrary regulatory minimum.

Checklist: nature and extent of risks by category (credit, liquidity, market); concentration by sector, geography, counterparty; credit quality analysis by internal rating/stage with gross and net exposures; contractual undiscounted maturity ladder for assets, liabilities, and off-balance-sheet items; interest rate, FX, and equity price sensitivity analysis; collateral held and its effect; capital management objectives and policies where relevant to risk; clear labeling of any cross-referenced, incorporated-by-reference risk report sections and their audit status.

• Providing generic boilerplate risk disclosure copied from a prior period or a peer bank rather than tailored to the entity'
• s actual portfolio composition
• presenting a liquidity gap analysis on a discounted or behavioral basis without also providing the required contractual undiscounted view
• omitting concentration disclosures for significant single-sector or single-name exposures
• showing sensitivity analysis using assumptions inconsistent with how the risk is actually managed internally
• failing to update the maturity ladder or sensitivity figures each period.